CD4 and COVID-19: However, in participants who did not experience any COVID-19-related symptoms or tested SARS-CoV-2 PCR-negative (despite reporting symptoms), nine out of 22 (40.9%) also exhibited a detectable SARS-CoV-2-specific CD4 T-cell response.